Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Neuroscience
|
May 11, 2019
The Role of S100B in Aerobic Training Efficacy in Older Adults with Mild Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial
C K Barha, G Y R Hsiung, T Liu-Ambrose
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 5, 2002
Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
G-Y R Hsiung, S K Das, R Ranawaya, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 31, 2012
Multiple pathologies are common in Alzheimer patients in clinical trials
B W Wang, E Lu, I R A Mackenzie, et al.
Neurology
|
May 24, 2006
Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia
S D Spacey, P J Adams, P C P Lam, et al.
Dementia and Geriatric Cognitive Disorders
|
April 21, 2007
Behavioural measures in frontotemporal lobar dementia and other dementias: the utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study
M Blair, A Kertesz, N Davis-Faroque, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials
H Liu, J Li, E Ziegemeier, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Neuroscience
|
May 11, 2019
The Role of S100B in Aerobic Training Efficacy in Older Adults with Mild Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial
C K Barha, G Y R Hsiung, T Liu-Ambrose
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 5, 2002
Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
G-Y R Hsiung, S K Das, R Ranawaya, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 31, 2012
Multiple pathologies are common in Alzheimer patients in clinical trials
B W Wang, E Lu, I R A Mackenzie, et al.
Neurology
|
May 24, 2006
Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia
S D Spacey, P J Adams, P C P Lam, et al.
Dementia and Geriatric Cognitive Disorders
|
April 21, 2007
Behavioural measures in frontotemporal lobar dementia and other dementias: the utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study
M Blair, A Kertesz, N Davis-Faroque, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials
H Liu, J Li, E Ziegemeier, et al.
Page
of 1